Evelo Biosciences rises on smaller Q2 loss

Evelo Biosciences

14/08/2023 16:16

** Shares of drug developer Evelo Biosciences Inc  EVLO.O 
up 4.7% at $10.53
    ** Co reports Q2 loss of $3.78 per share vs a loss of $8.07
per share a year ago 
    ** Co had cash and cash equivalents of $7.6 mln, as of
June 30
    ** EVLO shares down 67.3% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))